NetworkNewsBreaks

TuesdayMay 10, 2022 11:27 am

NetworkNewsBreaks – Austin Gold Corp. (NYSE American: AUST) Secures $13.85M in IPO

Austin Gold (NYSE American: AUST) recently announced the closing of its initial public offering of 3,265,000 of its common shares, each at a price of $4.00. The company also announced that the underwriters have exercised their option to acquire an additional 489,750 shares to cover overallotments in connection with the offering. The company has received approximately $13.85 million in net proceeds after the underwriting discount and estimated offering expenses. Roth Capital Partners acted as sole book-running manager and Pacific Century Securities acted as a co-manager for the offering. To view the full press release, visit https://nnw.fm/NLTxk About Austin Gold Corp.…

Continue Reading

TuesdayMay 10, 2022 10:51 am

NetworkNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Announces Webinar to Showcase Lidar Applications in Smart Infrastructure

Cepton (NASDAQ: CPTN), a Silicon Valley innovator and leader in high-performance MMT(R) lidar solutions, together with Lidar News will host a free webinar at 10:30 a.m. PT/1:30 p.m. ET on Tuesday, May 24, 2022. The webinar will focus on the use of lidar to enable higher levels of accuracy and efficiency of smart infrastructure applications, with examples of real-world deployments. Interested parties should visit https://nnw.fm/17KOi to register for the event. “As Cepton CEO Dr. Jun Pei always says, people’s desire for safety will never end,” said Cepton’s Director of Product Management and Marketing, Klaus Wagner. “Lidar not only enables high-precision…

Continue Reading

TuesdayMay 10, 2022 10:41 am

NetworkNewsBreaks – Eat Well Investment Group Inc.’s (CSE: EWG) (OTC: EWGFF) Releases Statement on Filing FY 2021 Financials, Other Required Documents

Eat Well Group (CSE: EWG) (OTC: EWGFF), a publicly traded investment company, has announced plans for filing its audited annual financial statements for the year ended Nov. 30, 2021; the company anticipates completing and filing the required documents by May 30, 2022. Eat Well also noted other documents, such as certificates of its CEO and CFO, that are related to the previously announced management cease trade order (“MCTO”) issued to Eat Well by the British Columbia Securities Commission. The company is working diligently to meet the guidelines in order to return to full trading status; those efforts include providing biweekly…

Continue Reading

MondayMay 09, 2022 2:15 pm

NetworkNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company currently developing a pipeline of cannabinoid-based pharmaceutical drug candidates to treat several diseases with high, unmet medical needs. The company’s focus is on rare cannabinoids, many of which are not yet available in commercial-size quantities, such as cannabidivarin – (“CBDV”) and tetrahydrocannabivarin – (“THCV”). “The acquisition of BayMedica in October 2021 has provided an advantage for InMed in the rare cannabinoid biosynthesis industry,” reads a recent article discussing the company. “BayMedica is a private U.S. firm specializing in the manufacturing and commercialization of rare cannabinoids for the health and wellness sector and…

Continue Reading

MondayMay 09, 2022 1:27 pm

NetworkNewsBreaks – Odyssey Health Inc. (ODYY) Announces Positive Results from Phase I Clinical Trial for Novel Drug to Treat Concussion

Odyssey Health (OTC: ODYY), f/k/a Odyssey Group International Inc., a company focused on developing unique, life-saving medical products, has announced positive results from the first group of patients dosed with PRV-002 in its phase I clinical trial. According to the update, Odyssey’s trial is administering PRV-002, its novel drug to treat concussion, to healthy human subjects. Thus far, the drug has shown to be safe and well tolerated. “Based on our animal data and after reviewing our initial phase I trial safety reports, we are optimistic that PRV-002 will be a safe option for the treatment of concussion,” said Michael…

Continue Reading

MondayMay 09, 2022 1:21 pm

NetworkNewsBreaks – Industrial Nanotech Inc. (INTK) Creating Talented Team to Drive Global Growth

Industrial Nanotech (OTC: INTK), a global leader in advance nanotechnology-based solutions for energy efficiency and sustainability, today announced that it has hired a global human relations and recruiting team headed by Charles Varela. In addition, the company announced six new enterprise account manager positions that were opened to drive global expansion. “At this moment in time, we have a portfolio of world class best-in-class products, and a massive pipeline full of projects for Fortune 100, Fortune 500 and Global 500 companies. As I stated in the last live Zoom presentation, we are focused 100% on excellent execution and building a…

Continue Reading

MondayMay 09, 2022 1:16 pm

NetworkNewsBreaks – Select Small and Micro-Cap Companies to Take the Stage at Roth Canada Showcase Day

Roth Capital Partners LLC (“Roth”) and Roth Canada Inc. (“Roth Canada”) today announced plans to co-host the Roth Canada Showcase Day on Tuesday, May 17, 2022. The event, slated to be held at 1 Hotel Central Park in New York City, will celebrate Roth Canada’s second anniversary as an IIROC investment dealer. “Our conferences provide unique opportunities for meaningful conversations and fostering relationships between companies and a wide spectrum of investors,” said Brady Fletcher, president and head of investment banking of Roth Canada. “At Roth Canada, we pride ourselves as a leader in capital formation and advisory services for growth…

Continue Reading

MondayMay 09, 2022 12:44 pm

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) Plans to Report Q1 2022 Results on May 16

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, has announced its intention to release its first quarter 2022 financial results after market close on Monday, May 16, 2022. As part of that release strategy, company executives will host a conference call/webcast to discuss the results and provide a corporate update on that same day; the call will include a Q&A session. The call is slated to start at 4:30 p.m. ET, and those who are interested can dial 1-844-825-9789 in the United States or 1-412-317-5180 internationally, using the conference ID 10166964; callers are encouraged to dial in at least 10…

Continue Reading

FridayMay 06, 2022 3:45 pm

NetworkNewsBreaks – Cepton Inc. (NASDAQ: CPTN) Committed to Bridge Divide Between Cutting-Edge Science and Automotive Industry

Cepton (NASDAQ: CPTN) recently became a sponsor and an exclusive LiDAR provider for ten universities in North America gathered in a four-year STEM education program called The AutoDrive Challenge(TM) II. The program is designed to advance STEM education and contribute to groundbreaking work within the autonomous driving space. “As a leading innovator in the LiDAR space, Cepton has always been committed to becoming the bridge between cutting-edge science and the automotive industry. Autonomous driving and its great enabler – LiDAR technology – are ready to take over the mobility space as the innovative technology makes strides in terms of decreasing…

Continue Reading

FridayMay 06, 2022 3:11 pm

NetworkNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH-Nicotine Pouch Performance to Be Compared to That of Leading Brands

Lexaria Bioscience Corp. (NASDAQ: LEXX) is expected to begin dosing for the NIC-H22-1 human study this summer. “NIC-H22-1, a pharmacokinetic randomized, double-blinded, cross-over study involving 36 human participants, will compare Lexaria’s DehydraTECH-nicotine pouch performance to that of existing leading brands available to U.S. customers, namely ON! and Zyn,” a recent article reads. The human study NIC-H22-1 is expected to build on the successes of the company’s animal studies, which have proven the technology’s effectiveness in promoting faster absorption, higher peak absorption, and greater overall quantities of nicotine, on average, in the blood than concentration-matched control formulations. “In 2021, the company…

Continue Reading